vs
American Bitcoin Corp.（ABTC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
American Bitcoin Corp.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$118.0M vs $69.8M），American Bitcoin Corp.同比增速更快（151.5% vs 21.2%），过去两年American Bitcoin Corp.的营收复合增速更高（296.9% vs 53.7%）
美国比特币公司专注于比特币相关业务领域。比特币是首个去中心化加密货币，由化名为中本聪的匿名人士于2008年发布白皮书后诞生，2009年随着开源代码上线正式投入使用，问世以来对全球金融与数字货币领域都产生了极为深远的影响。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ABTC vs RIGL — 直观对比
营收规模更大
ABTC
是对方的1.7倍
$69.8M
营收增速更快
ABTC
高出130.3%
21.2%
两年增速更快
ABTC
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 49.1% | 91.5% |
| 营业利润率 | -192.8% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 151.5% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-0.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTCRIGL
| Q4 25 | $118.0M | $69.8M | ||
| Q3 25 | $64.2M | $69.5M | ||
| Q2 25 | $1.4M | $101.7M | ||
| Q1 25 | $1.6M | $53.3M | ||
| Q4 24 | $46.9M | $57.6M | ||
| Q3 24 | $11.6M | $55.3M | ||
| Q2 24 | $5.5M | $36.8M | ||
| Q1 24 | $7.5M | $29.5M |
净利润ABTCRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $3.5M | $27.9M | ||
| Q2 25 | $3.4M | $59.6M | ||
| Q1 25 | $-100.6M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-576.0K | $12.4M | ||
| Q2 24 | $-61.1M | $-1.0M | ||
| Q1 24 | $230.4M | $-8.2M |
毛利率ABTCRIGL
| Q4 25 | 49.1% | 91.5% | ||
| Q3 25 | 56.0% | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | 57.9% | 89.9% | ||
| Q3 24 | 4.2% | 85.5% | ||
| Q2 24 | 31.0% | 92.4% | ||
| Q1 24 | 35.4% | 93.1% |
营业利润率ABTCRIGL
| Q4 25 | -192.8% | 33.2% | ||
| Q3 25 | 11.2% | 40.9% | ||
| Q2 25 | -162.1% | 60.1% | ||
| Q1 25 | -350.8% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | -87.8% | 25.4% | ||
| Q2 24 | -106.4% | 1.2% | ||
| Q1 24 | -20.8% | -23.6% |
净利率ABTCRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 5.4% | 40.2% | ||
| Q2 25 | 249.2% | 58.6% | ||
| Q1 25 | -6458.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -5.0% | 22.5% | ||
| Q2 24 | -1107.2% | -2.8% | ||
| Q1 24 | 3076.2% | -27.9% |
每股收益（稀释后）ABTCRIGL
| Q4 25 | $-0.07 | $14.11 | ||
| Q3 25 | $0.06 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.09 | $0.63 | ||
| Q4 24 | $1.10 | $0.82 | ||
| Q3 24 | $-0.15 | $0.70 | ||
| Q2 24 | $-0.10 | $-0.06 | ||
| Q1 24 | $-0.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $665.8M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ABTCRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | $750.0K | $108.4M | ||
| Q1 25 | $367.0K | $77.1M | ||
| Q4 24 | $850.0K | $77.3M | ||
| Q3 24 | $478.0K | $61.1M | ||
| Q2 24 | $1.4M | $49.1M | ||
| Q1 24 | $1.9M | $49.5M |
总债务ABTCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ABTCRIGL
| Q4 25 | $665.8M | $391.5M | ||
| Q3 25 | $575.5M | $117.6M | ||
| Q2 25 | $339.7M | $81.9M | ||
| Q1 25 | $115.8M | $18.6M | ||
| Q4 24 | $1.0B | $3.3M | ||
| Q3 24 | $697.5M | $-14.6M | ||
| Q2 24 | $614.3M | $-29.9M | ||
| Q1 24 | $696.8M | $-31.7M |
总资产ABTCRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $6.2M | $206.7M | ||
| Q1 25 | $9.0M | $176.0M | ||
| Q4 24 | $1.1B | $164.0M | ||
| Q3 24 | $7.5M | $139.4M | ||
| Q2 24 | $11.4M | $128.4M | ||
| Q1 24 | $17.8M | $126.5M |
负债/权益比ABTCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-79.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABTCRIGL
| Q4 25 | $-79.6M | $22.0M | ||
| Q3 25 | $-39.0M | $24.0M | ||
| Q2 25 | $-879.0K | $30.5M | ||
| Q1 25 | $-3.2M | $-893.0K | ||
| Q4 24 | $-54.0M | $14.5M | ||
| Q3 24 | $-76.8M | $21.7M | ||
| Q2 24 | $201.0K | $302.0K | ||
| Q1 24 | $-983.0K | $-5.0M |
自由现金流ABTCRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-60.6M | — | ||
| Q3 24 | $-79.3M | — | ||
| Q2 24 | $-874.0K | — | ||
| Q1 24 | — | — |
自由现金流率ABTCRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -104.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -129.2% | — | ||
| Q3 24 | -683.2% | — | ||
| Q2 24 | -15.8% | — | ||
| Q1 24 | — | — |
资本支出强度ABTCRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 40.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 21.6% | — | ||
| Q2 24 | 19.5% | — | ||
| Q1 24 | — | — |
现金转化率ABTCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -11.21× | 0.86× | ||
| Q2 25 | -0.26× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
